NeuroMetrix, Inc. Made Big Gain
Wed, Jul 21, 2021 at 05:30 PM
NeuroMetrix, Inc. (NURO:NASDAQ) shot up at $20.8, representing a gain of 107.2%. On Tue, Jul 20, 2021, NURO:NASDAQ touched a New 2-Week High of $10.04. The stock appeared on our News Catalysts scanner on Tue, Jul 20, 2021 at 07:39 PM in the 'BIOTECH' category. From Tue, Jul 06, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days
About NeuroMetrix, Inc. (NURO:NASDAQ)
NeuroMetrix Inc manufactures and sells wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests that help patients and physicians manage chronic pain, nerve diseases, and sleep disorders.
Top 10 Gainers:
- Chembio Diagnostics, Inc. (CEMI:NASDAQ), 159.22%
- NeuroMetrix, Inc. (NURO:NASDAQ), 107.17%
- Aehr Test Systems (AEHR:NASDAQ), 37.5%
- Studio City International Holdings Limited (MSC:NYSE), 35.89%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 29.47%
- NSPR (NSPR:NASDAQ), 29.1%
- LEXX (LEXX:NASDAQ), 28.07%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- Marin Software Incorporated (MRIN:NASDAQ), 24.2%
- Beyond Air, Inc. (XAIR:NASDAQ), 21.21%